Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
DFZQ $300 million notes offering
The investment-grade notes are due 2025
KKR $750 million senior notes offering
The investment-grade notes are due 2032
NXP $1.5 billion senior notes offering
The investment-grade offering includes $1 billion of green bonds
Investcorp India Acquisition $258.8 million IPO
The SPAC offering consists of 25,875,000 units
Frontier Communications $1.2 billion notes offering
The high-yield notes are due 2030
Bausch + Lomb $630 million IPO
We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
Constellation Brands $1.85 billion senior notes offering and tender offer
The tender offer was funded with the proceeds of the investment-grade notes offering
Qualcomm $1.5 billion notes offering
The investment-grade notes are due 2032 and 2052
Carvana $3.275 billion senior notes offering
The high-yield notes are due 2030
DFZQ €100 million bond offering
The Yulan bonds are due 2025